1Sturmer ML,Talajic M,Thibault B,et al.Anagement of atrial fibrillation in patients with congestive heart failure[J].Am J Geriatr Cardiol,2005,14(2):91-94.
2Olshansky B,Rosenfeld LE,Warner AL et al.The Atrial fibrillation follow-up investigation of rhythm management(AFFIRM)study:approaches to control rate in atrial fibrillation[J].J Am Co ll Cardiol.2004,43(7):1209-1210.
3EIhawaIy AM,Pang CC.ALpha Ib-adrenoceptors mediate renal tubular sodium and water readsorption in the rat[J].Br J Pharmacol,1994,111:819-824.
4Simons M,Downing SE.Coronary vasoconstriction and catecholamine cardiomyopathy[J].Am Heart J,1985,109(3):297-304.
6Kaumann AJ,Sanders L.Both beta 1-and beta 2-adrenoceptors mediate catecholamine-evoked arrhythmias in isolated human right atrium[J].Naunyn Schmiedebergs Arch Pharmacol,1993,348:536-540.
二级参考文献31
1[1]Sackner-Bemstein JD. Use of carvedilol in chronic heart failure: challenges in therapeutic management[ J ]. Prog Cardiovasc Dis, 1998,41 (suppl 1 ) :s53-s58.
2[2]Zweier JL. Measurement of superoxied derived free radicals inthe reperfused heart:Evidence Rui MV. Abreu, Dario JS. Santos,Antonio JM. Moreno for a free radical mechanism of reperfusion injury [J]. J Biol Chem, 1988,263: 1353-1357.
3[3]Cheng H Y, Randall CS, Holl WW, et al. Carvedilol-liposome interaction:evidence for strong association with the hydrophobic region of the lipid bilayers[J]. Biochem Biophys Acta, 1996,128:20-28.
4[4]Yue TL,Mckenna PJ,Gu JL,et al. Carvedilol,a new antihypertensive agent,prevents lipid peroxidation and oxidation injury to endothelial cells [J]. Hypertension, 1993,22:922-928.
5[5]Yue TL, Liu T, Feuerstein GZ. Carvedilol, a new bets adrenoceptor antagonist and vasodilator antihypoertensive drug, inhibits oxygen-radical-mediated lipid peroxidation in swine ventricular membranes [J]. Pharmacol Commun, 1992,1:27-35.
6[6]Yue TL,Wang X.Gu JL,et al. Carvedilol,a new vasodilating β-adrenoceptor anagonist, prevents low-density lipoprotein (LDL)-enhanced leukocyte adhesion to endothelial cells by inhibition of LDL oxidation [J]. Eur J Pharmacol, 1995,294:585-591.
7[7]Yue TL, Mckenna PJ, Ruffolo RR Jr,et al. Carvedilol,a new β-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils [J]. Eur J Pharmacol, 1992,214: 277 -280.
8[8]Christopher TG, Lopez BL,Ma XL,et al. Effects of a hydroxylated metabolite of the β-adrenoceptor antagonist,carvedilol,on post-ischaemic splanchnic tissue injury [J]. Br J Pharmacol, 1998,123: 292 -298.
9[9]Abreu RMV ,Santos DJSL,Moreno AJM. Effects of Carvediol and its analog BM910228 on mitochondrial function and oxidative stress [ J ]. J Pharmacol Exp Therapeut ,2000,295:1022-1030.
10[10]Oliveira PJ,Marques MPM ,de Carvalho LAEB. Effects of Carvedilol on isolated heart mitochondria: Evidence for a protonophoretic mechanism [ J ]. Biochem Biophys Res Commun,2000,276:82-87.
